Early research (Phase 1)Study completedNCT00552227
What this trial is testing
Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus
Who this might be right for
Diabetes Mellitus
Chromaderm, Inc. 48